Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine · Delayed Price · Currency is JOD · Price in USD 3.750
+0.160 (4.46%)
At close: Jul 28, 2026
Jerusalem Pharmaceuticals Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 50.19 | 48.95 | 39.82 | 39.65 | 46.14 | 46.23 |
Revenue Growth | 19.82% | 22.91% | 0.42% | -14.06% | -0.18% | 27.00% |
Gross Profit Gross Profit Growth | 29.04 | 27.52 | 20.12 | 21.34 | 23.14 | 22.79 |
Operating Income Operating Income Growth | 13.38 | 12.85 | 6.7 | 8.98 | 8.81 | 7.98 |
Net Income Net Income Growth | 10.22 | 10.18 | 5.04 | 6.96 | 7.17 | 6.6 |
Earnings Per Share EPS Growth | 0.28 | 0.28 | 0.14 | 0.19 | 0.20 | 0.18 |
EPS Growth | 48.89% | 102.13% | -27.58% | -3.02% | 8.73% | 77.11% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Sales Sector Pharmaceutical Sales Sector Growth | 50.17 | 48.93 | 39.8 | 39.46 | - | - |
ALL Other Sectors ALL Other Sectors Growth | 0.02 | 0.02 | 0.02 | 0.19 | 0.19 | 0.02 |
Total Total Growth | 50.19 | 48.95 | 39.82 | 39.65 | 46.14 | 46.23 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 11.57 | 12.22 | 11.74 | 6.64 | 7.79 | 5.49 |
Total Debt Total Debt Growth | 2.28 | 1.32 | 1.51 | 2.47 | 2.18 | 2.63 |
Net Cash (Debt) Net Cash Growth | 9.28 | 10.9 | 10.23 | 4.17 | 5.6 | 2.86 |
Net Cash Growth | -30.04% | 6.53% | 145.52% | -25.64% | 95.69% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.26 | 0.30 | 0.28 | 0.12 | 0.16 | 0.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1.86 | 3.62 | 11.75 | 9.2 | 17 | 6.05 |
Capital Expenditures CapEx Growth | -1.5 | -2.01 | -1.81 | -1.36 | -0.68 | -2.19 |
Free Cash Flow Free Cash Flow Growth | -3.36 | 1.61 | 9.94 | 7.84 | 16.32 | 3.86 |
Free Cash Flow Growth | - | -83.79% | 26.79% | -51.95% | 322.88% | 764.17% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.85% | 56.22% | 50.52% | 53.82% | 50.15% | 49.30% |
Operating Margin | 26.66% | 26.25% | 16.83% | 22.65% | 19.09% | 17.25% |
Pretax Margin | 25.93% | 26.22% | 16.62% | 22.24% | 19.57% | 16.49% |
Profit Margin | 20.37% | 20.80% | 12.65% | 17.54% | 15.55% | 14.27% |
FCF Margin | -6.69% | 3.29% | 24.96% | 19.77% | 35.37% | 8.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.053 | 0.075 | 0.040 | 0.050 | 0.075 | 0.060 |
Dividend Per Share Growth | 275.00% | 87.50% | -20.00% | -33.33% | 25.00% | 50.00% |
Dividend Yield | 2.00% | 3.34% | 2.19% | 2.83% | 5.10% | 4.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.21 | 8.13 | 13.68 | 9.83 | 8.23 | 7.72 |
P/FCF Ratio | - | 51.39 | 6.94 | 8.72 | 3.62 | 13.20 |
PS Ratio | 2.69 | 1.69 | 1.73 | 1.73 | 1.28 | 1.10 |